These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7177309)

  • 1. A neurobehavioral model of 2,5-hexanedione-induced neuropathy.
    Sterman AB; Sheppard RC
    Neurobehav Toxicol Teratol; 1982; 4(5):567-72. PubMed ID: 7177309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A correlative neurobehavioral-morphological model of acrylamide neuropathy.
    Sterman AB; Sheppard RC
    Neurobehav Toxicol Teratol; 1983; 5(1):151-9. PubMed ID: 6304547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biophysical and electrophysiological studies of hexanedione neurotoxicity.
    Nachtman JP; Couri D
    Neurotoxicology; 1981 Nov; 2(3):541-56. PubMed ID: 7199690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal atrophy is a specific component of 2,5-hexanedione peripheral neuropathy.
    Lehning EJ; Dyer KS; Jortner BS; LoPachin RM
    Toxicol Appl Pharmacol; 1995 Nov; 135(1):58-66. PubMed ID: 7482540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperbaric oxygen accelerates the neurotoxicity of 2,5-hexanedione.
    Rosenberg CK; Anthony DC; Szakál-Quin G; Genter MB; Graham DG
    Toxicol Appl Pharmacol; 1987 Feb; 87(2):374-9. PubMed ID: 3824391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexacarbon neuropathy: cell body changes are early, dynamic, and specific.
    Sterman AB
    Ann Neurol; 1984 Sep; 16(3):343-8. PubMed ID: 6486738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in terminal sprout formation in rat sternocostalis muscle during chronic intoxication with 2,5 hexanedione.
    Simonati A; Cavanagh JB
    Muscle Nerve; 1984 Jun; 7(5):355-61. PubMed ID: 6738573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxic effects of combined treatment of 2,5-hexanedione and triethyllead chloride.
    Lapadula DM; Tilson HA; Campbell G; Abou-Donia MB
    J Toxicol Environ Health; 1987; 21(4):483-92. PubMed ID: 3599091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of evidence for the size principle of selective vulnerability of axons in toxic neuropathies. I. The effects of subcutaneous injections of 2,5-hexanedione on behavior and muscle spindle function.
    De Rojas TC; Goldstein BD
    Toxicol Appl Pharmacol; 1990 Jun; 104(1):47-58. PubMed ID: 2141734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlated nerve conduction, somatosensory evoked potential and neuropathological studies in clioquinol and 2,5-hexanedione neurotoxicity in the baboon.
    Thomas PK; Bradley DJ; Bradley WA; Degen PH; Krinke G; Muddle J; Schaumburg HH; Skelton-Stroud PN; Thomann P; Tzebelikos E
    J Neurol Sci; 1984 Jun; 64(3):277-95. PubMed ID: 6236287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model studies for evaluating the neurobehavioral effects of complex hydrocarbon solvents II. Neurobehavioral effects of white spirit in rat and human.
    Lammers JH; Emmen HH; Muijser H; Hoogendijk EM; McKee RH; Owen DE; Kulig BM
    Neurotoxicology; 2007 Jul; 28(4):736-50. PubMed ID: 17433444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that pyrrole formation is a pathogenetic step in gamma-diketone neuropathy.
    Genter MB; Szakál-Quin G; Anderson CW; Anthony DC; Graham DG
    Toxicol Appl Pharmacol; 1987 Feb; 87(2):351-62. PubMed ID: 3103260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic deficits in peripheral nerve as a discriminator of early hexacarbon neurotoxicity.
    Anderson RJ; Dunham CB
    J Toxicol Environ Health; 1984; 13(4-6):835-43. PubMed ID: 6492204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological evaluation of toxic axonopathies in rats: acrylamide and 2,5-hexanedione.
    LoPachin RM; Ross JF; Reid ML; Das S; Mansukhani S; Lehning EJ
    Neurotoxicology; 2002 May; 23(1):95-110. PubMed ID: 12164553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of schedule of exposure to hexane in causing neurotoxicity.
    Pryor GT; Bingham LR; Dickinson J; Rebert CS; Howd RA
    Neurobehav Toxicol Teratol; 1982; 4(1):71-8. PubMed ID: 7070571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative neurotoxicity and pyrrole-forming potential of 2,5-hexanedione and perdeuterio-2,5-hexanedione in the rat.
    DeCaprio AP; Briggs RG; Jackowski SJ; Kim JC
    Toxicol Appl Pharmacol; 1988 Jan; 92(1):75-85. PubMed ID: 3341029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in rat axonal cytoskeletal proteins induced by in vitro and in vivo 2,5-hexanedione exposure.
    DeCaprio AP; O'Neill EA
    Toxicol Appl Pharmacol; 1985 Apr; 78(2):235-47. PubMed ID: 3929425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motoneuron axosomatic synapses are altered in axonopathy.
    Sterman AB; Sposito N
    J Neuropathol Exp Neurol; 1984 Mar; 43(2):201-9. PubMed ID: 6707705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autonomic-cardiovascular dysfunction accompanies sensory-motor impairment during acrylamide intoxication.
    Sterman AB; Panasci DJ; Sheppard RC
    Neurotoxicology; 1983; 4(1):45-52. PubMed ID: 6683826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of 2,5-hexanedione neurotoxicity by methyl ethyl ketone.
    Ralston WH; Hilderbrand RL; Uddin DE; Andersen ME; Gardier RW
    Toxicol Appl Pharmacol; 1985 Nov; 81(2):319-27. PubMed ID: 4060157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.